- Home
- IMAB vs RFM Comparison
IMAB vs RFM Comparison
Compare IMAB & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- RFM
- Stock Information
- Founded
- IMAB 2014
- RFM 2020
- Country
- IMAB United States
- RFM United States
- Employees
- IMAB N/A
- RFM N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- RFM Finance/Investors Services
- Sector
- IMAB Health Care
- RFM Finance
- Exchange
- IMAB Nasdaq
- RFM Nasdaq
- Market Cap
- IMAB 79.9M
- RFM 92.3M
- IPO Year
- IMAB 2020
- RFM N/A
- Fundamental
- Price
- IMAB $0.84
- RFM $15.10
- Analyst Decision
- IMAB Strong Buy
- RFM
- Analyst Count
- IMAB 3
- RFM 0
- Target Price
- IMAB $8.00
- RFM N/A
- AVG Volume (30 Days)
- IMAB 216.1K
- RFM 20.7K
- Earning Date
- IMAB 03-21-2025
- RFM 01-01-0001
- Dividend Yield
- IMAB N/A
- RFM 9.74%
- EPS Growth
- IMAB N/A
- RFM N/A
- EPS
- IMAB N/A
- RFM N/A
- Revenue
- IMAB $569,464.00
- RFM N/A
- Revenue This Year
- IMAB N/A
- RFM N/A
- Revenue Next Year
- IMAB N/A
- RFM N/A
- P/E Ratio
- IMAB N/A
- RFM N/A
- Revenue Growth
- IMAB N/A
- RFM N/A
- 52 Week Low
- IMAB $0.76
- RFM $12.89
- 52 Week High
- IMAB $2.00
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- IMAB 38.53
- RFM 29.61
- Support Level
- IMAB $0.78
- RFM $15.37
- Resistance Level
- IMAB $0.93
- RFM $15.25
- Average True Range (ATR)
- IMAB 0.07
- RFM 0.11
- MACD
- IMAB -0.01
- RFM -0.06
- Stochastic Oscillator
- IMAB 33.45
- RFM 3.13
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.